Clinical Trials on Mucositis in India

Total 12 results

Tata Memorial Centre

Recruiting

Randomized Trial of Curcumin to Reduce Mucositis in Autologous Transplant Setting

Oral Mucositis (Ulcerative)

India
All India Institute of Medical Sciences, New Delhi

Withdrawn

A Phase III Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-Dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Myeloablative Hematopoietic Stem Cell Transplantation (mucositis)

Oral Mucositis in Patients Undergoing HSCT

India
Tata Memorial Centre

Completed

Ability of Curcumin to Decrease Cytokines Involved in Mucositis in the Autologous Transplant

Oral Mucositis (Ulcerative)

India
All India Institute of Medical Sciences, New Delhi

Completed

A Pilot Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation

Oral Mucositis

India
Panineeya Mahavidyalaya Institute of Dental Sciences...
Saveetha University; MNJ Institute of Oncology & Regional cancer Center

Completed

Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers

Oral Mucositis

India
Piramal Enterprises Limited

Completed

A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00

Radiation Induced Mucositis in Head and Neck Cancer

India
Tosk, Inc.
SIRO Clinpharm Pvt. Ltd.

Active, not recruiting

Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690

Mucositis

India
Tosk, Inc.
Crystal Life Sciences

Completed

Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690 (TK112690)

Mucositis

India
Tosk, Inc.
SIRO Clinpharm Private Limited

Active, not recruiting

Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690

Mucositis

India
Mucosal Therapeutics

Completed

Efficacy of SNX-1012 in the Treatment of Oral Mucositis

Stomatitis | Oral Mucositis

United States, India
Pfizer

Recruiting

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

Myositis

China, United States, Japan, Korea, Republic of, Taiwan, Spain, Germany, Hungary, Poland, Argentina, Italy, India, Belgium, Mexico, France, Slovakia, Bulgaria
AstraZeneca

Not yet recruiting

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis) (JASMINE)

Polymyositis, Dermatomyositis

United States, Denmark, France, Italy, Spain, Belgium, India, Vietnam, Japan, China, Israel, Austria, Canada, Germany, Taiwan, United Kingdom, Australia, Hungary, Netherlands, Sweden, Brazil, Bulgaria, Poland, Mexico, Czechia

3

Subscribe